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Abstract: 
Heparin plays a significant role in wound-healing and tissue regeneration applications, through 
stabilisation of fibroblast growth factors (FGF). Risks associated with batch-to-batch variability 
and contamination from its biological sources have led to the development of synthetic highly 
sulfonated polymers as promising heparin mimics. In this work, a systematic study of an 
aqueous polymerisation-induced self-assembly (PISA) of styrene from poly(2-acrylamido-2-
methylpropane sodium sulfonate) (P(AMPS)) macro-RAFT agents produced a variety of 
spherical heparin mimicking nanoparticles, which were further characterised with light 
scattering and electron microscopy techniques. None of the nanoparticles tested showed 
toxicity against mammalian cells, however significant haemolytic activity was observed. 
Nonetheless, the heparin mimicking nanoparticles outperformed both heparin and linear 
                                                 
a Supporting Information ((bold)) is available online from the Wiley Online Library or from the author. 
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P(AMPS) in cellular proliferation assays, suggesting increased bFGF stabilisation efficiencies 
possibly due to the high density of sulfonated moieties at the particle surface. 
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1. Introduction  
 
Heparin is an endogenous highly sulphated polysaccharide imperative to many biological 
processes such as; anticoagulation, protein binding and the anti-inflammatory response.[1-3] Its 
biological activity is typically associated with its high charge density, which allows for strong 
electrostatic interactions with over 400 different proteins.[4] In particular, heparins ability to 
bind to and stabilise the basic fibroblast growth factor (bFGF), and its role in aiding 
complexation with the receptor, has attracted significant interest due to its essential function in 
cell proliferation, tissue regeneration and wound healing. Despite its heavy clinical use, this 
versatile polysaccharide can only be sourced from animal tissues (typically bovine and porcine), 
raising major biological safety concerns (virus contamination and large batch-batch 
variation/variable patient response). To overcome these challenges, researchers have studied 
the bFGF stabilisation efficiency of a variety of linear polysulfated/sulfonated heparin mimics, 
including sulfated glycopolymers, polyaromatics and polystyrenes and polyacrylamides.[5-9] 
For example, Maynard and co-workers recently showed 200% proliferative activity (similar to 
heparin + bFGF) of human dermal fibroblast cells after addition of bFGF stabilised with 
polystyrenesulfonate copolymers.[9] 
 
Nanoparticles (NPs) are now well established in biomedicine for enhanced drug delivery,[10] 
bio-imaging[11] and diagnostics applications.[12] Their large size promotes extended circulation 
times and in the case of cancer treatment, they demonstrate passive tumour accumulation via 
the enhanced permeability and retention (EPR) effect.[13, 14] Furthermore, their high surface area 
can be functionalised with a broad range of moieties, making them ideal candidates for protein 
binding.[15] Although the synthesis of sulfonated/sulfated polymeric NPs has already been 
explored,[16-18] only one report exists on synthetic heparin mimicking NPs as growth factor 
stabilisers.[19] Koide et al. recently reported a library of polymeric NPs based on glycosylated 
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sulfated/sulfonated polyacrylamides able to stabilise a vascular endothelial growth factor 
(VEGF165) which outperformed heparin in protein binding and anti-angiogenic experiments.
[19] 
This pioneering study revealed huge potential for NP heparin mimics, but as of yet has not been 
explored in the stabilisation of bFGF.  
 
NP’s designed with advanced controlled radical polymerisation techniques, such as reversible 
addition fragmentation chain transfer mediated (RAFT) polymerisation induced self-assembly 
(PISA) can be exploited to overcome these challenges.[20, 21] PISA is typically performed 
through chain extension of a solvophilic macro-RAFT agent with either: a solvophilic monomer 
which when polymerised becomes solvophobic (RAFT dispersion polymerisation); or a 
solvophobic monomer (RAFT emulsion polymerisation).[22-24] This results in the formation of 
sterically stabilised, diblock copolymer core-shell NPs, where the particle surface is decorated 
with the solvophilic block of the stabilising macro-RAFT agent. Using this approach many 
parameters such as particle size, and stabiliser chain length can be modified, hence most PISA 
studies focus on nano-object synthesis and morphology control.[25-28] However, this synthetic 
approach has also been used for a wide range of applications. For instance, Whittaker and co-
workers reported polyethylene glycol (PEG) coated NPs, copolymerised with a 19F containing 
monomer synthesised via PISA for an in vitro cellular uptake study using magnetic nuclear 
resonance (MRI).[29] Furthermore, Ladmiral et al. reported PISA using a galactose functional 
monomer to enhance delivery of a model drug via cell surface lectin binding.[30] We have 
recently reported synthesis of polyacrylamide coated NPs via RAFT emulsion polymerisation, 
and their use as micro-RNA vectors and their in vivo biodistribution.[23, 31]  Outside of biological 
applications, Armes and co-workers recently reported the synthesis of sulfated NPs via PISA 
both in dispersion and emulsion to further understand NP occlusion in calcite and zinc oxide 
crystals.[32, 33] Due to the highly sulfated nature of the above NPs, we envisaged that similar 
systems may be able to act as heparin mimics. However, to the best of our knowledge, there are 
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no reports of synthetic heparin mimicking NPs specifically applied to bFGF stabilisation, or 
indeed any other growth factor than VEGF165.
[19]  
 
Herein we report the synthesis of a series of heparin mimicking core-shell NPs via RAFT 
mediated PISA of styrene from poly(2-acrylamido-2-methyl propane sulfonic acid) (P(AMPS)) 
macro-RAFT agents. The NPs were characterised via dynamic light scattering and electron 
microscopy. Their toxicity and membrane (haemolytic) activity was evaluated in vitro on 
murine embryonic fibroblast cells (NIH-3T3) and erythrocytes, respectively. Finally the bFGF 
stabilisation efficiency was determined through an in vitro proliferation assay using IL-3 
dependent murine pro B cells (BaF3), which are engineered to over-express FGF receptors and 
do not produce heparin themselves. 
 
2. Results and Discussion 
2.1 Synthesis of linear polymers 
Firstly, a series of three P(AMPS) homopolymers (DP20, DP50 and DP100) were prepared via 
aqueous RAFT polymerisation at 90°C using BDMAT as chain transfer agent, and VA-086 as 
thermal initiator (Figure 1A).[34] All three polymers had narrow molar mass distributions (Ð < 
1.2; Error! Reference source not found.) with similar experimental and theoretical molecular 
weights determined via 1H NMR spectroscopy. Molecular weights determined by aqueous SEC 
deviated slightly from the theoretical values, likely due to the differences in hydrodynamic 
volume of the P(AMPS) homopolymers with the poly(ethyleneglycol)  calibration. (Error! 
Reference source not found.-S3; Error! Reference source not found.).  
 
 
2.2 Preliminary synthesis 
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Since P(AMPS) macro-RAFT agent synthesis was carried out in water and reached full 
monomer conversion, emulsion polymerisations could be performed directly without macro-
RAFT agent purification. In a preliminary NP synthesis, P(AMPS)50 was diluted in distilled 
water, and directly chain extended with styrene (5 wt % monomer; 450 units) at 80°C, using 
ACVA as a thermal initiator, 1 mM P(AMPS)50 and 400 RPM stirring (Error! Reference 
source not found.; Figure 1A). The reaction was sampled periodically for 8 h to follow 
conversion, molar mass and particle size evolution over time. Between 0 - 1 h, negligible 
monomer conversion was observed (determined via gravimetry, Figure 1E), likely due to the 
low aqueous styrene concentration prior to micellisation. However after 1 h, both monomer 
conversion and particle size (measured with DLS; Figure 1C) rapidly increased, suggesting the 
formation of nano-objects and transport of styrene monomer into the growing particles. Both 
particle size and monomer conversion plateaued after 6 h at 78.5 nm and 96% respectively, 
indicating completion of the reaction. It should be noted that the latter time points exhibited 
artificial conversion values greater than 100%, we anticipate this is due to small weighing errors 
associated with the scale and volume of both the polymerisation and the samples taken.  TEM 
analysis of the final latex (t = 8 h) revealed spherical NPs (Figure 1F) with relatively high 
polydispersity not revealed by DLS (PDi = 0.052; Error! Reference source not found. – Latex 
1), possibly due to skewed sensitivity for larger species in light scattering. The polydispersity 
may be attributed to the ionic macro-RAFT agents reducing chain extension efficiency, 
affecting the uniformity of particle growth by electrostatic repulsion of similarly charged 
species in the aqueous phase.[35] This finding may also be attributed to the swollen corona in 
DLS measurements, which may artificially decrease the resulting PDi in comparison to TEM, 
in which the corona is fully collapsed. The highly amphiphilic block copolymer NPs were 
insoluble in traditional SEC eluents for polystyrene characterisation (THF, CHCl3), therefore 
analyses were performed in DMF eluent with 0.1 wt % LiBr with polar columns. Since PS is 
known to swell in DMF and is not ideal for molecular weight determination, SEC 
7 
 
chromatograms were only used to qualitatively assess molecular weight evolution and macro-
RAFT agent consumption. Using these, a clear increasing trend in molar mass over time was 
observed (Figure 1D), suggesting chain extension from P(AMPS)50 had indeed occurred, 
however, some macro-RAFT agent remained unconsumed. Nonetheless, the highly negative 
zetapotentials of the NPs (-56.4 mV), suggests a dense sulfonated polymeric shell at the NP 
surface.   
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Figure 1 General synthesis scheme (A) and schematic representation (B) for the preparation of 
P(AMPS) macro-RAFT agents, and subsequent PISA via chain extension with styrene to 
generate P(AMPS) coated nanoparticles. Kinetic data for Latex 1 (C) particle diameter (green 
A 
B 
C D 
t = 8 h 
F 
E 
Chain extension 
Polymerisation induced 
self-assembly RAFT polymerisation 
AMPS® Styrene 
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circles) and polydispersity index (red circles) as measured via DLS, (D) molar mass evolution 
of the dissolved nanoparticle unimers as measured via DMF SEC (E) styrene conversion as 
measured via gravimetric techniques and (F) representative TEM image at 8 h time point.  
 
2.3 Systematic study 
A systematic study on initiator type, temperature, initiator concentration, stirring speed, 
polystyrene DP, P(AMPS) DP and hydrophobic monomer type was then performed to improve 
nanoparticle polydispersity and control particle size. It should be noted that many of the latexes 
described below were completely insoluble in the DMF + 0.1 wt % LiBr SEC eluent, therefore 
for clarity only the particle size via DLS and TEM is discussed. Full characterisation and 
reaction conditions can be found in the supplementary information (Table S2). 
 
2.3.1. Effect of initiator 
 
The above-mentioned polymerisation was repeated using similar conditions but replacing 
ACVA (Latex 1) with VA-086 (Latex 2) and VA-057 (Latex 3). To account for the different 10 
h half-life temperatures, the concentration of each initiator was adjusted such that the same 
number of radicals was generated within 6 h (Equation S2 and S3). Interestingly, the NPs 
synthesised with VA-086 were larger (94.2 nm) than with ACVA (78.5 nm), while those with 
VA-057 were smaller (59.6 nm). It is likely that as a neutral initiator VA-086 impart less 
electrostatic stabilisation to the growing particles resulting in fewer larger particles comprised 
of a higher number of polymer chains. A charged initiator, ACVA, was therefore used for all 
future polymerisations as no clear differences other than particle size were observed. [36, 37] 
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2.3.2. Effect of temperature 
 
Similarly, the preliminary polymerisation at 80°C (Latex 1) was repeated at both 70°C (Latex 
4) and 90°C (Latex 5), again with adjusted amounts of initiator as detailed above. At 70°C, only 
71% conversion was attained, while at higher temperatures (80 and 90°C) monomer 
conversions higher than 90% were achieved likely due to higher propagation rates. Both 
temperatures yielded larger nanoparticles (91.4 nm at 70°C and 100.4 nm at 90°C). The 
difference at 70°C, could be explained by a decreased solubility of styrene during the early 
phase of the emulsion polymerisation, resulting in fewer macro-RAFT agents being chain 
extended, resulting in less colloidal stability.[38] At 90°C the increase in size could however be 
attributed to particle-particle coalescence at high temperatures.[39] 
 
2.3.3. Effect of initiator concentration 
 
By increasing the concentration of initiator (ACVA) (Latex 1; [CTA]0/[I]0 = 4.65) to double 
(Latex 6; [CTA]0/[I]0 = 2.33) and quadruple (Latex 7; [CTA]0/[I]0 = 0.93) the original amount, 
only a small increase in particle size was observed (78.5 nm (Latex 1) to approximately 95 nm 
for both concentrations). In both cases it is likely that an increased number of radicals may only 
result in more termination in the aqueous phase, thus leaving the effective radical concentration 
in the growing particles unaffected by [I]0.  
 
2.3.4. Effect of stirring speed  
 
Increasing the stirring speed from 400 RPM (Latex 1) to 800 RPM (Latex 8) and 1200 RPM 
(Latex 9) resulted in larger NP diameters, (128.5 nm (800 RPM) and 157.7 nm (1200 RPM)). 
The faster, and possibly asymmetrical agitation (1200 RPM) may promote inter-particle 
coalescence, and therefore larger diameters.[40] Transmission electron micrographs of these NPs 
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however revealed uniform suspensions at 800 rpm, which most likely had uniform stirring. This 
stirring speed was therefore used for all future experiments.  
 
2.3.5 Effect of polystyrene chain length 
 
It has been widely reported that the balance of hydrophilic and hydrophobic chain length can 
heavily influence particle size and morphology in PISA formulations.[21] It was possible to 
modify the hydrophobic length (core forming block) by either increasing [P(AMPS)50]0 or 
reducing [Styrene]0 in the emulsion polymerisations. This was attempted by targeting a 
polystyrene core with a DP of 250 (Latex 10 and Latex 12) and 50 (Latex 11 and Latex 13) 
compared to the Latex 8 (DPtarget = 450) by reducing [Styrene]0 or increasing [macro-RAFT]0. 
Targeting a DP of 250 both gave smaller NPs, 120.7 nm and 92.4 nm for [Styrene]0 equal to 
250 and 50 mM, respectively, of which both phenomena have been previously reported for 
similar systems.[24, 35] Further decreasing the DPtarget to 50 however resulted in the absence of 
nano-object formation, suggesting that this was below the critical hydrophobic chain length for 
self-assembly using this type of anionic macro-RAFT agent. If compared to non-ionic 
stabilisers however, many reports indicate that very short hydrophobic chain lengths are able to 
induce micellisation, e.g below DP20.[25] 
 
2.3.6 Effect of P(AMPS) chain length 
 
Using the synthesised homopolymers P(AMPS)20 (Latex 15) and P(AMPS)100 (Latex 16), 
RAFT emulsion polymerisations analogous to Latex 8 (P(AMPS)50) were then performed. For 
the shorter macro-RAFT agent (DP = 20), a huge increase in particle size was observed (248.8 
nm) compared to DP50 (120.7 nm), probably due to the reduced electrostatic stability of the 
growing particles, leading to coalescence. Unexpectedly, larger diameters (161.6 nm) were also 
observed with increased chain length (Latex 16, P(AMPS)100 macro-RAFT agent). It is possible 
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that this higher overall charge may promote chain-chain repulsion and therefore a reduced 
number at the surface of the growing particles, with the total effect of less colloidal stability 
and larger particles. This could also improve the rate of radical entry and therefore account for 
the increase in NP uniformity with P(AMPS)20 and P(AMPS)100 stabilisers. It is also possible 
that the larger (DP 100 vs DP 50) swollen anionic corona is partially responsible for this 
increase in size observed in DLS.[41]  
 
2.3.7. Effect of hydrophobic monomer 
 
Finally, polymerisations were conducted replacing styrene (Latex 8) with n-butyl acrylate, 
another well-established monomer for emulsion polymerisations (Latex 14). This resulted in 
larger NPs (200.5 nm), which can be attributed to the poorer reinitiation of an acrylamide 
macro-RAFT agent with an acrylate monomer, thus reducing the number of sulfonated chains 
at the particle surface. It should be noted that due the low Tg of P(n-BA), Latex 14 was imaged 
with cryo-transmission electron microscopy, instead of in the dry state. 
 
In general, altering the conditions of polymerisation of these sulfonated systems did not 
dramatically affect the resulting NP size. However, stirring speed and P(AMPS) chain length 
had the greatest effect on particle size and polydispersity. The average diameter of all NPs 
synthesised was found to be comparable between DLS and TEM measurements, while all zeta-
potentials remained similar (~ -55 to -65 mV) regardless of polymerisation conditions. All of 
the final latexes had pH values between 6.5 and 6.6 which is most probably caused by the 
P(AMPS) macro-RAFT agent/surface functionality. Furthermore, unlike other monomer 
combinations, our emulsion system only yielded spherical NPs, which was also observed by 
Armes and co-workers when using sulfated polymethacrylate macro-RAFT agent stabilisers.[32, 
33]  
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Figure 2 DLS particle size distributions (top row) (intensity = green, volume = black, number 
= red) measured in water at 25˚C and TEM images (bottom row) of Latex 8, Latex 14 (cryogenic 
TEM) and Latex 16.  
Table 1 Characterisation data for the nanoparticles used in biological studies.  
    Water  PBS 
 Target 
structure 
Monomer 
Conv 
[%]a) 
Dh 
[nm]b) 
PDic) 
ZP 
[mV]d) 
 
Dh 
[nm]b) 
PDic) 
Latex 
8 
P(AMPS)50-
b-PS450 
Styrene 90 128.5 0.052 -60.3 
 
122.0 0.072 
Latex 
14 
P(AMPS)50-
P(n-BA)450 
n-BA 93 200.5 0.051 -62.9 
 
206.4 0.044 
Latex 
16  
P(AMPS)100-
PS450 
Styrene 89 161.6 0.050 -61.6 
 
165.7 0.047 
 
aDetermined using gravimetric techniques. bDetermined using DLS (intensity distribution). 
cCalculated using equation S4. dDetermined using a zetasizer.  
 
 
 
 
 
 
3.4. Biological studies 
Latex 8 Latex 16 
1 10 100 1000 10000
Diameter (nm)
 Intensity
 Volume
 Number
Latex 8 
1 10 100 1000 10000
Diameter (nm)
 Intensity
 Volume
 Number Latex 16 
1 10 100 1000 10000
Diameter (nm)
 Intensity
 Volume
 Number
Latex 14 
Latex 14 
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Figure 3 (A) haemolytic activity (controls of PBS and water) and (B) cytotoxicity against NIH-
3T3 fibroblasts of heparin, P(AMPS)50, Latex 16 P(AMPS)100-PS450, Latex 14 P(AMPS)50-P(n-
BA)450 and Latex 8 P(AMPS)50-PS450 against controls of untreated cells. (C) bFGF stabilisation 
as characterised via BaF3 proliferation (controls of bFGF only). Data shown represent mean ± 
standard deviation across triplicates from two independent experiments (N=6).    
 
Latex 8 (P(AMPS)50-b-PS450), Latex 14 (P(AMPS)50-P(n-BA)450) and Latex 16 (P(AMPS)100-
PS450) were chosen to study their heparin mimicking behaviour in order to isolate differences 
between the influence of core monomer (n-BA and styrene) and AMPS chain length (DP50 and 
DP100) on bFGF stabilisation. Additionally, these samples appeared as the most uniform from 
TEM images (Figure 2). Prior to these experiments, the NPs were dialysed for 48 h against a 
100 kDa MWCO membrane to remove any styrene monomer, and unconsumed macro-RAFT 
agent which may compete against the NPs in biological studies. Importantly, the hydrodynamic 
diameter of the chosen latexes was comparable in PBS and in water, suggesting the NPs would 
be colloidally stable in biological experiments (Table 1). P(AMPS)50 and heparin itself were 
also included in these experiments for comparison. 
 
The haemolytic activity of all compounds was assessed by incubating red blood cells (1 h at 
37°C) with the chosen NPs and polymers at four concentrations (100 µg mL-1 to 1 µg mL-1 in 
PBS) and monitoring the release of haemoglobin via UV spectroscopy at 414 nm. Positive 
(Triton-X) and negative (PBS) membrane disruption controls were also performed in parallel, 
A B C 
FG
F
H
ep
ar
in
P
(A
M
P
S
) 50
La
te
x 
16
 P
(A
M
P
S
) 10
0
-P
S 45
0
La
te
x 
14
 P
(A
M
P
S
) 50
-P
(n
-B
A
) 45
0
La
te
x 
8 
P
(A
M
P
S
) 50
-P
S 45
0
0
50
100
150
200
250
300
350
400  10 µg mL
-1
 50 µg mL
-1
 100 µg mL
-1
P
ro
lif
e
ra
ti
o
n
 (
%
)
H
ep
ar
in
P
(A
M
P
S
) 50
La
te
x 
16
 P
(A
M
P
S
) 10
0
-P
S 45
0
La
te
x 
14
 P
(A
M
P
S
) 50
-P
(n
-B
A
) 45
0
La
te
x 
8 
P
(A
M
P
S
) 50
-P
S 45
0
W
at
er
0
20
40
60
80
100
120
%
 H
a
e
m
o
ly
s
is
 1 µg mL
-1
 10 µg mL
-1
 50 µg mL
-1
 100 µg mL
-1
0.001 0.01 0.1 1 10 100 1000 10000
0
20
40
60
80
100
120
140
160
C
e
ll 
v
ia
b
ili
ty
 (
%
)
Concentration (µg mL
-1
)
 Heparin  P(AMPS)
50
 
 Latex 8 P(AMPS)
50
-PS
450
 Latex 14 P(AMPS)
50
-P(n-BA)
450
 
 Latex 16 P(AMPS)
100
-PS
450
15 
 
with water (5% in PBS) also used as a vehicle control. Low haemolytic activity (~20%), 
comparable to H2O, were observed for heparin and P(AMPS)50, however much higher activity 
(> 50 % haemolysis) was seen for all of the NPs following the trend Latex 8 (P(AMPS)50-PS450 
particles) > Latex 14 (P(AMPS)50-P(n-BA)450 particles) > Latex 15 (P(AMPS)100-PS450 
particles) (Figure 3A). In contrast, none of the compounds (polymers or NPs) showed acute 
toxicity towards murine embryonic fibroblast cells for concentrations up to 1 mg mL-1 (Figure 
3B). This major difference between haemolysis and cytotoxicity could be due to the highly 
amphiphilic ‘surfactant-like’ nature of the particle surface-core interface, which is known to 
have significant membrane disruption activity.[42] The observed trend appear to support this 
hypothesis, as the large P(AMPS)100 chains present on the surface of Latex 15 will better shield 
erythrocytes from the PS interface compared to the shorter P(AMPS)50. Furthermore, P(n-BA) 
is less hydrophobic than PS, and therefore NPs with these cores may be less amphiphilic, 
accounting for the reduction in haemolytic activity of Latex 14.  
 
Finally, stabilisation of bFGF was tested using a typical proliferation assay using BaF3 cells, 
an IL-3 dependent murine pro B cell line which was modified to lack cell-surface heparin 
sulfate, and express the bFGF receptor (FGFr1c). Using this assay, heparin or a heparin mimic 
must be present to stabilise bFGF and promote its binding to FGFr1c receptor, thus inducing 
enhanced cellular proliferation. To assess this, the NPs, P(AMPS)50 and heparin (100, 10 and 1 
µg mL-1) were incubated with BaF3 cells and bFGF (5 ng mL-1) for 48 h, and the cellular 
proliferation evaluated with a cell viability assay (CellTiter-Blue®). Results were normalised to 
untreated cells (100%) (Figure 3C). Addition of heparin induced a small amount of proliferation 
(150%) which appeared independent of concentration for the range studied.[8] The linear 
polymer, P(AMPS)50, resulted in approximately 250% proliferation. In contrast, all of the NPs 
displayed greater than 400% cellular proliferation, with no obvious differences between core 
composition, P(AMPS) shell length, or concentration. The full mechanism of the bFGF-
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heparin-bFGFR proliferation pathway is not yet fully understood, however the key 
requirements are now known.[43] Heparin must induce dimerization of bFGF and 
simultaneously bind to bFGFR to achieve the active bFGF-heparin-bFGFR triplex required for 
effective proliferation.[43] A recent study by Zbinden et al. revealed that polymer conjugates 
with increased display of bFGF drastically enhanced proliferation of endothelial cells.[44] They 
also noted that higher densities of bFGF resulted in larger conjugate hydrodynamic volumes, 
which may also contribute to this effect.[44]  It is probable that our large NPs with numerous 
surface-active P(AMPS) chains may be able to bind multiple bFGF on same species, thus 
improving its multivalent display. However, the smaller size and of linear P(AMPS)50 and 
heparin could mean that only one, or a few of the polymers can interact with a single bFGF 
molecule, potentially explaining the greater cellular proliferation with the NPs. Furthermore, 
Garcia-Fernandez et al. showed that greater hydrophobicity of sulfonated linear polymers had 
a profound increase on bFGF stability, therefore exposed styrene from the hydrophobic NP 
cores may also have a similar effect.[45] It should be noted that our study evaluates cellular 
proliferation heparin as a function of treatment weight (e.g. 1 g of NP’s vs 1 g of polymer). 
However, due to the higher weight proportion of PS compared to P(AMPS) in our NPs, in 
reality the molar concentration of sulfonated residues is exceptionally low in the NP’s compared 
to the counterpart polymers. This highlights how the use of NP architecture could have an even 
greater efficacy if the number of P(AMPS) chains per particle could be elucidated, and 
sulfonated moieties directly compared. 
 
 
Conclusions  
In conclusion, we have shown a parameter screening study to generate uniform, heparin 
mimicking polystyrene NPs via aqueous RAFT emulsion polymerisation/PISA from P(AMPS) 
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hydrophilic macro-RAFT agents. The optimised NPs showed no cytotoxic effect against NIH-
3T3 fibroblasts. However, compared to linear P(AMPS) and heparin, the NPs displayed major 
disruption of erythrocytes rationalised by the highly amphiphilic nature of the P(AMPS)-PS 
interface. Finally, all of the tested NPs exhibited much greater cellular proliferation, in 
comparison to heparin and linear P(AMPS) control polymers, likely due to the multivalent 
presentation of sulfonated chains at the NP surface. However, no apparent trends were observed 
between nanoparticle varieties (core properties and surface chain length) on cell proliferation. 
Overall, the polymerisation-induced self-assembly approach allows the facile generation of 
highly sulfonated NPs, and represent a promising platform for heparin mimicry in the future.  
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